XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Statement of Earnings (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 10,143 $ 10,410 $ 29,868 $ 33,562 Close
Cost of products sold, excluding amortization of intangible assets 4,605 4,629 13,419 14,549
Amortization of intangible assets 496 498 1,485 1,517
Research and development 672 782 2,041 2,163
Selling, general and administrative 2,723 2,731 8,225 8,275
Total operating cost and expenses 8,496 8,640 25,170 26,504 Close
Operating earnings 1,647 1,770 4,698 7,058 Close
Interest expense 166 141 478 404 Close
Interest (income) (97) (55) (296) (95) Close
Net foreign exchange (gain) loss (10) 19 17 16 Close
Other (income) expense, net (83) (93) (370) (253) CloseClose
Total Other Income Expenses -24.0 12.0 -171.0 72.0 0.0 Close
Earnings before taxes 1,671 1,758 4,869 6,986 CloseClose
Taxes on earnings 235 323 740 1,086
Net Earnings $ 1,436 $ 1,435 $ 4,129 $ 5,900 Close
Basic Earnings Per Common Share (in dollars per share) $ 0.82 $ 0.82 $ 2.36 $ 3.35
Diluted Earnings Per Common Share (in dollars per share) $ 0.82 $ 0.81 $ 2.35 $ 3.32
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) 1,738,700 1,752,968 1,740,255 1,756,209
Dilutive Common Stock Options (in shares) 9,589 10,685 9,819 11,638
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares) 1,748,289 1,763,653 1,750,074 1,767,847
Outstanding Common Stock Options Having No Dilutive Effect (in shares) 7,334 5,445 5,474 2,655